Preface |
|
xi | |
Contributing Authors |
|
xiii | |
Part I: Pathophysiology of Heart Failure |
|
|
Evolving Concepts of the Pathogenesis of Heart Failure |
|
|
3 | (6) |
|
|
|
|
|
The Molecular and Celluar Biology of Cardiac Failure |
|
|
9 | (32) |
|
|
|
|
|
Progression from Cardiac Hypertrophy to Heart Failure |
|
|
41 | (26) |
|
|
|
|
|
Abnormalities in Cardiac Contraction: Systolic Dysfunction |
|
|
67 | (16) |
|
|
|
|
|
Abnormalities of Myocardial Relaxation and Filling: Diastolic Dysfunction |
|
|
83 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiac Remodeling in Congestive Heart Failure |
|
|
101 | (16) |
|
|
|
|
|
Remodeling of the Cardiac Intersitium in Ischemic Cardiomyopathy |
|
|
117 | (20) |
|
|
|
|
|
|
|
|
|
Age-Associated Changes in the Cardiovascular System in the Absence of Cardiovascular Disease |
|
|
137 | (20) |
|
|
|
|
|
|
|
|
|
The Role of the Pericardium in the Pathophysiology of Heart Failure |
|
|
157 | (32) |
|
|
|
|
|
The Sympathetic Nervous System in Heart Failure |
|
|
189 | (10) |
|
|
|
|
|
Hormonal Alternations in Heart Failure |
|
|
199 | (14) |
|
|
|
|
|
Cytokines as Mediators of Disease Progression in the Failing Heart |
|
|
213 | (20) |
|
|
|
|
|
The Peripheral Circulation in Heart Failure |
|
|
233 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Renal Salt and Water Handling in Congestive Heart Failure |
|
|
253 | (16) |
|
|
|
|
|
|
|
|
Part II: Differential Diagnosis of Congestive Heart Failure |
|
|
Heart Failure Secondary to Coronary Artery Disease |
|
|
269 | (12) |
|
|
|
|
|
|
|
|
|
|
281 | (32) |
|
|
|
|
|
|
|
|
|
Inflammatory Heart Disease |
|
|
313 | (12) |
|
|
|
|
|
|
|
|
|
Congestive Heart Failure as a Consequence of Valvular Heart Disease |
|
|
325 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Heart Failure Secondary to Congenital Heart Disease |
|
|
343 | (18) |
|
|
|
|
|
|
|
|
|
|
361 | (22) |
|
|
|
|
|
|
|
|
|
The Impact of Comorbidity on the Presentation and Outcome of Heart Failure |
|
|
383 | (18) |
|
|
|
|
|
|
|
|
Part III: Pharmacologic Therapy of Heart Failure |
|
|
Clinical Pharmacokinetics in Congestive Heart Failure |
|
|
401 | (20) |
|
|
|
|
|
|
|
|
|
|
421 | (14) |
|
|
|
|
|
|
435 | (20) |
|
|
|
|
|
|
|
|
|
Inhibition of the Renin-Angiotensin System in the Treatment of Heart Failure: Rationale, Results, and Current Recommendations |
|
|
455 | (18) |
|
|
|
|
|
Non-ACE Inhibitor Vasodilators |
|
|
473 | (42) |
|
|
|
|
|
|
|
|
|
Use of β-Adrenergic Blocking Agents for the Treatment of Chronic Heart Failure |
|
|
515 | (18) |
|
|
|
|
|
|
533 | (20) |
|
|
|
|
|
|
|
|
Part IV: Therapeutic Approach in Acute Heart Failure |
|
|
Management of Acute and Decompensated Heart Failure |
|
|
553 | (18) |
|
|
|
|
|
Use of Mechanical Devices in Treating Heart Failure |
|
|
571 | (12) |
|
|
|
|
|
|
|
|
|
Dialysis and Hemofiltration for Congestive Heart Failure |
|
|
583 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Surgical Therapy for Acute Congestive Heart Failure |
|
|
603 | (12) |
|
|
|
|
|
|
|
|
Part V: Approach to Patients with Chronic Heart Failure |
|
|
Physical Examination in Heart Failure |
|
|
615 | (14) |
|
|
|
|
|
Noninvasive Diagnostic Assessment of the Patient with Heart Failure |
|
|
629 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prognosis in Heart Failure |
|
|
655 | (18) |
|
|
|
|
|
The Medical Management of Chronic Congestive Heart Failure |
|
|
673 | (22) |
|
|
|
|
|
|
695 | (6) |
|
|
|
|
|
Exercise and Rehabilitation in Congestive Heart Failure |
|
|
701 | (10) |
|
|
|
|
|
|
|
|
|
Management of Supraventricular Arrhythmias in Patients with Congestive Heart Failure |
|
|
711 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Management of Ventricular Arrhythmias |
|
|
725 | (18) |
|
|
|
|
|
Pathogenesis and Therapy of Thrombosis in Patients with Congestive Heart Failure |
|
|
743 | (24) |
|
|
|
|
|
|
|
|
|
Surgical Treatment of Chronic Heart Failure |
|
|
767 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
785 | (26) |
|
|
|
|
Part VI: What Does the Future Hold? |
|
|
|
811 | (6) |
|
|
|
|
|
|
|
|
Subject Index |
|
817 | |